![De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudine]()
De novo entecavir+adefovir dipivoxil+lamivudine triple-resistance mutations resulting from sequential therapy with adefovir dipivoxil, and lamivudineYang, Song; Xing, Huichun; Wang, Qi; Wang, Xiaomei; Liu, Shunai; Cheng, Jun · Annals of Clinical Microbiology and Antimicrobials · 2016